Company intelligence / Profile preview

Novorx Therapeutics

Thane, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Novorx Therapeutics is an India-based specialty pharmaceutical company focused initially on ophthalmology. The company presents itself as a science-driven, ethically marketed pharma organization developing and commercializing ophthalmic formulations intended to support retinal health, macular protection, and long-term visual wellness. Publicly available information suggests it is an early-stage commercial specialty pharma business rather than a clinical-stage biotech developer with a disclosed novel R&D pipeline. The business appears to be newly formed, privately held, and headquartered in the Thane/Mumbai area of Maharashtra, India.

Therapeutic areas: Ophthalmology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Novorx Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novorx Therapeutics.

Explore the full profile